Yamasaki S - Search Results

1

Cellular interaction against autologous tumor cells between IL-2-cultured lymphocytes and fresh peripheral blood lymphocytes in patients with breast cancer given immuno-chemotherapy.

Yamasaki S, Kan N, Mise K, Harada T, Ichinose Y, Moriguchi Y, Kodama H, Satoh K, Ohgaki K, Tobe T. Yamasaki S, et al. Biotherapy. 1993;6(1):63-71. doi: 10.1007/BF01877387. Biotherapy. 1993. PMID: 8507545

2

[Experimental study on the optimal treatment schedule for combination of BRM (immunostimulators, cultured killer cells or interleukin-2) and chemotherapy].

Kan N, Okino T, Satoh K, Mise K, Teramura Y, Yamasaki S, Harada T, Ohgaki K, Tobe T. Kan N, et al. Among authors: yamasaki s. Gan To Kagaku Ryoho. 1990 Aug;17(8 Pt 1):1421-7. Gan To Kagaku Ryoho. 1990. PMID: 2389941 Japanese.

3

Effect of heat treatment on tumor cells and antitumor effector cells.

Mise K, Kan N, Okino T, Nakanishi M, Satoh K, Teramura Y, Yamasaki S, Ohgaki K, Tobe T. Mise K, et al. Among authors: yamasaki s. Cancer Res. 1990 Oct 1;50(19):6199-202. Cancer Res. 1990. PMID: 2400985

4

Therapeutic efficacy of sequential therapy with OK-432, cyclophosphamide, IL2-cultured lymphocytes and in vivo IL2 against advanced murine plasmacytoma.

Kan N, Okino T, Nakanishi M, Sato K, Mise K, Yamasaki S, Teramura Y, Ohgaki K, Tobe T. Kan N, et al. Among authors: yamasaki s. Biotherapy. 1989;1(3):197-206. doi: 10.1007/BF02170888. Biotherapy. 1989. PMID: 2642023

5

[The therapeutic effects of OK-432 combined adoptive immunotherapy (AIT) against liver metastases of breast cancer].

Okino T, Kan N, Nakanishi M, Satoh K, Mise K, Yamasaki S, Teramura Y, Hori T, Kodama H, Ohgaki K, et al. Okino T, et al. Among authors: yamasaki s. Gan To Kagaku Ryoho. 1989 Apr;16(4 Pt 2-3):1913-9. Gan To Kagaku Ryoho. 1989. PMID: 2730083 Japanese.

6

Bone metastasis as a prognostic factor in breast cancer patients with liver metastasis given OK-432-combined adoptive immunotherapy via the hepatic artery.

Kan N, Yamasaki S, Kodama H, Okino T, Ichinose Y, Moriguchi Y, Li L, Sugie T, Imamura M. Kan N, et al. Among authors: yamasaki s. Biotherapy. 1993;6(4):245-50. doi: 10.1007/BF01878353. Biotherapy. 1993. PMID: 8018445

7

Relationship between immunological parameters and survival of patients with liver metastases from breast cancer given immuno-chemotherapy.

Yamasaki S, Kan N, Harada T, Ichinose Y, Moriguchi Y, Li L, Sugie T, Kodama H, Satoh K, Ohgaki K. Yamasaki S, et al. Breast Cancer Res Treat. 1993;26(1):55-65. doi: 10.1007/BF00682700. Breast Cancer Res Treat. 1993. PMID: 8400324 Clinical Trial.

8

The therapeutic effect of OK-432-combined adoptive immunotherapy against liver metastases from gastric or colorectal cancers.

Satoh K, Kan N, Okino T, Mise K, Yamasaki S, Harada T, Hori T, Ohgaki K, Tobe T. Satoh K, et al. Among authors: yamasaki s. Biotherapy. 1993;6(1):41-9. doi: 10.1007/BF01877385. Biotherapy. 1993. PMID: 8507544

9

Analysis of effector cells in tumor-bearing mice pre-treated with active specific immunization followed by cyclophosphamide.

Li L, Okino T, Kan N, Yamasaki S, Ichinose Y, Sugie T, Kanaoka S, Imamura M. Li L, et al. Among authors: yamasaki s. Biotherapy. 1998;11(4):223-8. doi: 10.1023/a:1008054611739. Biotherapy. 1998. PMID: 9950097

10

Therapeutic and life-prolonging effect of intrapleural injection with a streptococcal preparation, OK-432, and IL2-cultured effusion lymphocytes to breast cancer patients with malignant pleural effusion.

Hori T, Mise K, Kan N, Okino T, Satoh K, Yamasaki S, Teramura Y, Harada T, Ohgaki K, Kodama H, et al. Hori T, et al. Among authors: yamasaki s. Biotherapy. 1992;5(1):21-9. doi: 10.1007/BF02194783. Biotherapy. 1992. PMID: 1389900

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,708 results

Search Page

Filters